These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 30659330)

  • 21. Update on Ovarian Sex Cord-Stromal Tumors.
    Ordulu Z
    Clin Lab Med; 2023 Jun; 43(2):245-274. PubMed ID: 37169445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on Ovarian Sex Cord-Stromal Tumors.
    Ordulu Z
    Surg Pathol Clin; 2022 Jun; 15(2):235-258. PubMed ID: 35715160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review on Sertoli-Leydig Cell Tumours of the Ovary.
    Muscat C; Calleja-Agius J
    Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian endometrioid carcinomas resembling sex cord-stromal tumors. An immunohistochemical study.
    Aguirre P; Thor AD; Scully RE
    Int J Gynecol Pathol; 1989; 8(4):364-73. PubMed ID: 2478493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare DICER1 and Absent FOXL2 Mutations Characterize Ovarian Juvenile Granulosa Cell Tumors.
    Baillard P; Genestie C; Croce S; Descotes F; Rouleau E; Treilleux I; Gouy S; Morice P; Ray-Coquard I; McCluggage WG; Devouassoux-Shisheboran M
    Am J Surg Pathol; 2021 Feb; 45(2):223-229. PubMed ID: 32910017
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
    Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
    Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of monoclonal antibody against human inhibin as a marker for sex cord-stromal tumors of the ovary.
    Rishi M; Howard LN; Bratthauer GL; Tavassoli FA
    Am J Surg Pathol; 1997 May; 21(5):583-9. PubMed ID: 9158684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sertoli-Leydig Cell Tumors of the Ovary With Follicular Differentiation Often Resembling Juvenile Granulosa Cell Tumor: A Report of 38 Cases Including Comments on Sex Cord-Stromal Tumors of Mixed Forms (So-called Gynandroblastoma).
    Ordulu Z; Young RH
    Am J Surg Pathol; 2021 Jan; 45(1):59-67. PubMed ID: 32815828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study.
    Kommoss F; Oliva E; Bhan AK; Young RH; Scully RE
    Mod Pathol; 1998 Jul; 11(7):656-64. PubMed ID: 9688187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ovarian endometrioid carcinomas simulating sex cord-stromal tumors: a study using inhibin and cytokeratin 7.
    Guerrieri C; Frånlund B; Malmström H; Boeryd B
    Int J Gynecol Pathol; 1998 Jul; 17(3):266-71. PubMed ID: 9656124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of mutation of DICER1 and FOXL2 genes in microcystic stromal tumor of the ovary.
    Meurgey A; Descotes F; Mery-Lamarche E; Devouassoux-Shisheboran M
    Virchows Arch; 2017 Feb; 470(2):225-229. PubMed ID: 27830327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
    McCluggage WG; McKenna M; McBride HA
    Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative immunohistochemical analysis of granulosa and sertoli components in ovarian sex cord-stromal tumors with mixed differentiation: potential implications for derivation of sertoli differentiation in ovarian tumors.
    Vang R; Herrmann ME; Tavassoli FA
    Int J Gynecol Pathol; 2004 Apr; 23(2):151-61. PubMed ID: 15084844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
    Oliva E; Garcia-Miralles N; Vu Q; Young RH
    Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
    McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
    Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 37. Sclerosis in Sex Cord-Stromal Tumors Other Than the Sclerosing Stromal Tumor: A Report of 70 Cases.
    Devins KM; Young RH
    Am J Surg Pathol; 2023 Jul; 47(7):774-784. PubMed ID: 37184091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 14-3-3 sigma is a useful immunohistochemical marker for diagnosing ovarian granulosa cell tumors and steroid cell tumors.
    Chen L; Yang B
    Int J Gynecol Pathol; 2013 Mar; 32(2):156-62. PubMed ID: 23370648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex steroid biosynthesis enzymes in ovarian sex-cord stromal tumors.
    Costa MJ; Morris R; Sasano H
    Int J Gynecol Pathol; 1994 Apr; 13(2):109-19. PubMed ID: 8005731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
    Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
    Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.